LONQUEX

This brand name is authorized in Austria, Australia, Brazil, Estonia, Spain, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Turkey, United Kingdom

Active ingredients

The drug LONQUEX contains one active pharmaceutical ingredient (API):

1 Lipegfilgrastim
UNII 4AWF0N6QV3 - LIPEGFILGRASTIM

Lipegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Lipegfilgrastim binds to human the G-CSF receptor like filgrastim and pegfilgrastim. Human G-CSF is a glycoprotein that regulates the production and release of functional neutrophils from the bone marrow.

Read about Lipegfilgrastim

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
LONQUEX Solution for injection in pre-filled syringe European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L03AA14 L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors
Discover more medicines within L03AA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 10931H, 10936N
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 537515080006702
Country: EE Ravimiamet Identifier(s): 1621763
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 113856001
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 559551
Country: FR Base de données publique des médicaments Identifier(s): 64198267
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 241107
Country: IE Health Products Regulatory Authority Identifier(s): 88171
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 7617
Country: IT Agenzia del Farmaco Identifier(s): 042919011, 042919023, 042919047, 042919050
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1071089, 1071090
Country: NL Z-Index G-Standaard, PRK Identifier(s): 110450
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 19024
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100300779
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W65723001, W65723002
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699638955374

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.